Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia

Case Reports in Hematology
Stephen E LangabeerChristopher L Bacon

Abstract

The development of acute lymphoblastic leukemia in an existing myeloproliferative neoplasm is rare with historical cases unable to differentiate between concomitant malignancies or leukemic transformation. Molecular studies of coexisting JAK2 V617F-positive myeloproliferative neoplasms and mature B cell malignancies indicate distinct disease entities arising in myeloid and lymphoid committed hematopoietic progenitor cells, respectively. Mutations of CALR in essential thrombocythemia appear to be associated with a distinct phenotype and a lower risk of thrombosis yet their impact on disease progression is less well defined. The as yet undescribed scenario of pro-B cell acute lymphoblastic leukemia arising in CALR mutated essential thrombocythemia is presented. Intensive treatment for the leukemia allowed for expansion of the original CALR mutated clone. Whether CALR mutations in myeloproliferative neoplasms predispose to the acquisition of additional malignancies, particularly lymphoproliferative disorders, is not yet known.

References

Jul 1, 1978·Annals of Internal Medicine·R HoffmanR P McCaffrey
Feb 1, 1986·The American Journal of Medicine·T A BraichB R Greenberg
Dec 1, 1986·Journal of Clinical Pathology·A M O'HeaC Bunch
Jan 1, 1987·Clinical and Laboratory Haematology·R AitchisonM F Greaves
May 1, 1994·Journal of Clinical Pathology·J R NeilsonB J Boughton
Aug 1, 1996·American Journal of Clinical Pathology·K K Woronzoff-Dashkoff, C E Litz
Feb 26, 1999·Leukemia & Lymphoma·M CamósE Montserrat
May 15, 2007·Cancer Genetics and Cytogenetics·Ulrike BacherClaudia Haferlach
Feb 12, 2009·American Journal of Hematology·Francesca PalandriNicola Vianelli
Jun 18, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Alessandro M VannucchiAlberto Bosi
May 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Magnus BjörkholmOla Landgren
Feb 7, 2012·Leukemia & Lymphoma·Maro OhanianFarhad Ravandi
Dec 12, 2013·The New England Journal of Medicine·Thorsten KlampflRobert Kralovics
Dec 25, 2013·Blood·Elisa RumiUNKNOWN Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators
Dec 29, 2013·Blood·Giada RotunnoUNKNOWN Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators
Apr 23, 2014·British Journal of Haematology·Karl HaslamEibhlin Conneally
Apr 23, 2014·American Journal of Hematology·Ayalew TefferiFrancesco Passamonti
Jul 22, 2014·European Journal of Haematology·Helna PetterssonBjörn Andréasson
Aug 12, 2014·British Journal of Haematology·Adrian P TrifaIoan V Pop
May 8, 2015·European Journal of Haematology·Stephen E LangabeerUNKNOWN MPN&MPNr-EuroNet
Jul 18, 2015·American Journal of Clinical Pathology·Magdalena Czader, Attilio Orazi
Oct 22, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Tunde KrahlingHajnalka Andrikovics
Nov 6, 2015·Mediators of Inflammation·Sylvie HermouetBetty Gardie

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
flow cytometry

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.